United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Ginkgo Bioworks (NYSE: DNA) wins $47m DOE contract to build AI-enabled cloud lab platform Ginkgo Bioworks wins $47M PNNL contract to build modular AI-ready phenotyping platform. Find out how this move boosts its federal bioeconomy play. byVenkateshDecember 5, 2025